Clinical Trial Update: Albumin for Management of Hypervolemic Hyponatremia (AlbuCAT) [Phase 2]

View source ↗

Summary

Phase 2 trial (AlbuCAT) evaluating albumin for management of hypervolemic hyponatremia in patients with cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hyponatremia

Drugs mentioned

• Albumin

Snippet

Sponsor: Fundacion Clinic per a la Recerca Biomédica | Conditions: Hyponatremia With Excess Extracellular Fluid Volume, Cirrhosis, Liver | Phase 2 | Status: COMPLETED